Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Lialda, Mezavant, Mezavant XL, mesalamine (MMX Mesalazine) (GED 0001, MD-0901, SPD476)
Also known as: formerly Mesavance
print preview
bookmark
share with colleague
General Information
Company
Shire plc
Description
5-aminosalicylate (5-ASA) mesalamine formulated using Multi-Matrix system (MMX) technology
Molecular Target
Cyclooxygenases (COX)
Mechanism of Action
Cyclooxygenase (COX) inhibitor
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy